Telomerase-pulsed dendritic cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma.
Angela Märten(Boehringer Ingelheim (United States)), Schmidt-Wolf Ig, Holger Strunk(University of Bonn), Peter Albers(Düsseldorf University Hospital), Christian Franchy, A Schmiedel, T. Sauerbruch, Elisabeth Sievers(Karolinska University Hospital), Schild Hh, von Ruecker A
PubMed
February 13, 2006
Cited by 10
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I
|European Urology|2008|617
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603